The process by which clinical trial agreements (CTAs) are developed often has a tremendous impact on study start-up – affecting site-level budgets, payment terms, and Clinical Trial Management Systems (CTMS) set-up. There are many challenges involved in executing global CTAs and, in turn, performing investigator payments in clinical research, but a number of these challenges can be averted with proper planning and execution in the budget development stage.
Read this white paper to understand the most important considerations for a fully-integrated process that results in high-efficiency enabled contracts and payments.
Most Recent Flipbooks
Six Practices of High Performing Clinical Research Sites
Learn what high-performing research sites have in common, and what makes sponsors return to them again and again.
Looking Ahead to 2018: Insights into Clinical Research Trends from Our Experts
In this paper, WCG thought-leaders provide insights on what they anticipate in 2018 in clinical trial technology, regulatory changes, and scientific developments.
Gene Therapy & Immunotherapy Glossary, 2nd Edition
The Second Edition of WCG’s wildly popular Alphabetical Glossary of Terms in Gene Therapy and Immunotherapy.
Investigational Drugs Outside of Clinical Trials - Understanding Expanded Access and Right-to-Try
Managing the Unmanageable: Meeting the Challenge of Appropriate Safety Report Distribution
